GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Monogram Technologies Inc (NAS:MGRM) » Definitions » Debt-to-Equity

Monogram Technologies (Monogram Technologies) Debt-to-Equity : 0.05 (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Monogram Technologies Debt-to-Equity?

Monogram Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.13 Mil. Monogram Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.33 Mil. Monogram Technologies's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $10.23 Mil. Monogram Technologies's debt to equity for the quarter that ended in Mar. 2024 was 0.05.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Monogram Technologies's Debt-to-Equity or its related term are showing as below:

MGRM' s Debt-to-Equity Range Over the Past 10 Years
Min: -7.72   Med: 0.04   Max: 0.72
Current: 0.05

During the past 7 years, the highest Debt-to-Equity Ratio of Monogram Technologies was 0.72. The lowest was -7.72. And the median was 0.04.

MGRM's Debt-to-Equity is ranked better than
80.54% of 704 companies
in the Medical Devices & Instruments industry
Industry Median: 0.215 vs MGRM: 0.05

Monogram Technologies Debt-to-Equity Historical Data

The historical data trend for Monogram Technologies's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Monogram Technologies Debt-to-Equity Chart

Monogram Technologies Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial -7.72 0.04 0.06 0.15 0.04

Monogram Technologies Quarterly Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.72 0.05 0.04 0.04 0.05

Competitive Comparison of Monogram Technologies's Debt-to-Equity

For the Medical Devices subindustry, Monogram Technologies's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Monogram Technologies's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Monogram Technologies's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Monogram Technologies's Debt-to-Equity falls into.



Monogram Technologies Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Monogram Technologies's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Monogram Technologies's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Monogram Technologies  (NAS:MGRM) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Monogram Technologies Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Monogram Technologies's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Monogram Technologies (Monogram Technologies) Business Description

Traded in Other Exchanges
Address
3913 Todd Lane, Suite 307, Austin, TX, USA, 78744
Monogram Orthopaedics Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.
Executives
Paul H Riss director
Noel Knape officer: Chief Financial Officer 3913 TODD LANE, AUSTIN TX 78744
Benjamin Sexson director, 10 percent owner, officer: Chief Executive Officer 3913 TODD LANE, AUSTIN TX 78744
Noel Goddard director 3913 TODD LANE, AUSTIN TX 78744
Kamran Shamaei officer: Chief Technology Officer 3913 TODD LANE, AUSTIN TX 78744
Douglas Unis director 3913 TODD LANE, AUSTIN TX 78744